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Neuron
Previewsnovel role for autophagy in developmental
dendritic spine pruning that provides
further insight into this carefully regulated
shaping of synaptic connections that
when dysregulated could contribute to
the behavioral deficits observed in ASD.
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Critical unmet clinical needs are the treatment of epilepsy without side effects and prevention of sudden un-
expected death in epilepsy, or SUDEP. In this issue ofNeuron, Qi et al. (2014), define how hyper-SUMOylation
impacts K+ channel activity in vivo and could serve as a potential pathway for development of novel epilepsy
therapeutics.The rate of sudden death in patients with
epilepsy is over 20 times higher than in
the general population (Shorvon and
Tomson, 2011). Sudden unexpected
death in epilepsy, or SUDEP, is the pri-
mary cause of mortality in patients with
epileptic disorders. Although SUDEP is
clearly linked to mutations in ion chan-
nels (Auerbach et al., 2013; Glasscock
et al., 2010; Goldman et al., 2009; Ka-
lume et al., 2013; Massey et al., 2014;
Surges and Sander, 2012), the specific
underlying pathophysiological mecha-
nism(s) remains elusive, and biomarkers
are not currently available. Thus, SUDEP
represents a major unmet clinical need
and a current focus of intense inves-tigation. Animal model and clinical
studies show that, in addition to neuronal
synchrony and hyperexcitability, respira-
tory and cardiovascular abnormalities
during and after seizures contribute to
SUDEP, suggesting important interac-
tions between brain and heart. In this
issue of Neuron, Qi et al. (2014) give
new perspective to the growing list of
potential SUDEP mechanisms, propos-
ing that genes within the ion channel
protein interactome may be pathogenic
candidates.
Looking beyond mutations in ion chan-
nels themselves, Qi and colleagues (Qi
et al., 2014) examine the in vivo role of
the dynamic processes of SUMOylationonneuronal excitability and its relationship
to SUDEP and seizures. SUMOylation, the
addition of ubiquitin-likeSUMO-modifying
groups to lysine residues, and subsequent
de-SUMOylation by Sentrin/SUMO-spe-
cific protease (SENPs), is known to alter
protein function and localization in multi-
ple tissues, including brain and heart
(Droescher et al., 2013; Wang, 2011). To
explore the role of SENP2 in SUMOylation
in vivo, Qi et al. generated a floxed SENP2
allele. Unexpectedly, the authors found
that SENPfxN/fxN mice, in which the
neomycin cassette was retained within
the floxed SENP2 allele, developed spon-
taneous convulsive seizures and died at
6–8 weeks with 100% penetrance.
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PreviewsInterestingly,SENPfx/fxmice, generatedby
removing the neomycin cassette from the
floxed allele by FLP-mediated recombina-
tion, livednormal lifespans.Real-timePCR
and western blot analyses revealed that
SENP2 mRNA and protein levels were
significantly reduced in SENPfxN/fxN mice
compared to SENP+/+ or SENPfxN/+ mice.
SENP mRNA and protein levels in
SENPfx/fx mice were similar to those
measured in SENP+/+ mice, indicating
that, as observed by previous investiga-
tors generating floxed alleles (e.g., Levin
andMeisler, 2004), the neomycin cassette
interfered with SENP2 expression, result-
ing in a hypomorphic allele.
Because SENP2 protein is respon-
sible for de-SUMOylation, the authors of
this study proposed that SENP2 defi-
ciency may result in increased levels
of SUMOylation. Consistent with this,
SUMO-1- and SUMO-2/3-conjugated
proteins were found to accumulate in
brain and heart in SENPfxN/fxN mice.
Real-time PCR analysis showed that
SUMO-1 and SUMO-2/3 mRNA levels
were similar between genotypes, indi-
cating that accumulation of SUMOylated
proteins was not due to overexpression
of SUMOs themselves.
SENPfxN/fxN mice are hyperexcitable.
Video electroencephalogram (EEG) re-
cordings revealed spontaneous behav-
ioral seizures in regions of the cortex
and hippocampus. Whole-cell patch-
clamp recordings of hippocampal CA3
pyramidal neurons in acute brain slices
prepared from SENPfxN/fxN mice showed
hyperexcitability, including spontaneous
firing, increased evoked firing frequency,
and repetitive bursting upon mossy fiber
stimulation. How does this happen?
With previous work demonstrating that
SUMOylation of voltage-gated K+ chan-
nels alters neuronal firing (Wilkinson
et al., 2010), one potential mechanism is
that hyper-SUMOylation of K+ channels
underlies the increased excitability of the
SENPfxN/fxN hippocampal circuitry. Exam-
ination of the subcellular localization and
extent of SUMOylation of K+ channels in
the hippocampus revealed that although
localizations of Kv1.1 and Kv7.2 K+ chan-
nels previously implicated in epilepsy
were similar in cultured SENP+/+ and
SENPfxN/fxN hippocampal neurons, there
was an enrichment of SUMOylated
Kv1.1 and Kv7.2/Kv7.3 in SENPfxN/fxNmice in whole-brain immunopreciptation
experiments. As an additional clue to the
puzzle, whole-cell patch-clamp analysis
of SENPfxN/fxN hippocampal CA3 neurons
showed significantly diminished M-cur-
rents (mediated by Kv7 channels) but no
differences in dendrotoxin-sensitive cur-
rents (mediated by Kv1.1), suggesting
that the increased SUMOylation in the
SENPfxN/fxN neurons likely did not impact
the channel localization and levels but is
critical for modulating M-currents.
M-channels are unique ligand-regu-
lated and voltage-dependent K+ channels
with distinct physiological and phar-
macological characteristics that are sup-
pressed by muscarinic acetylcholine
receptor agonists such as acetylcholine.
M-channel expression has been recorded
from many types of cells in the peripheral
and central nervous systems, including
hippocampal neurons. Both KCNQ2 and
KCNQ3, encoding Kv7.2 and Kv7.3,
respectively, have been proposed to ex-
press M-currents. Because of its unique
modulation by acetylcholine and its noni-
nactivating in nature, M-current plays a
critical role in controlling the subthreshold
electrical excitability of neurons as well as
their responsiveness to synaptic inputs.
Blockade or closure of M-channels facili-
tates membrane depolarization and fast
excitatory transmission, which in turn
allows neurons to more readily fire action
potentials. Consistent with this, the
authors found that application of retiga-
bine, a Kv7 channel opener, significantly
suppressed neuronal hyperexcitability in
SENPfxN/fxN mice.
The authors reasoned that if SENP2
deficiency led to reduced M-current
and subsequent hyperexcitability in
SENPfxN/fxN hippocampal CA3 neurons,
restoration of SENP2 polypeptide levels
should rescue M-current and suppress
neuronal hyperexcitability. Indeed, when
dialyzed SENPfxN/fxN CA3 neurons were
presented with active or inactive SENP2
peptides, the presence of SENP2 pep-
tides in the pipette solution significantly
potentiated M-current and suppressed
neuronal hyperexcitability while the
heat-denatured SENP2 peptides had no
effect. These results strongly supported
the notion that SENP2 polypeptide defi-
ciency, leading to M-current reduction,
was responsible for hippocampal neuronal
hyperexcitability in SENPfxN/fxNmice.Neuron 83, SHow does SENP2 deficiency-induced
hyperexcitability lead to SUDEP? One
possibility is that SENP2fxN/fxN mice
may have cardiac defects that would
contribute to early death. By moni-
toring electrocardiograms in freely mov-
ing mice, the authors found that the
SENP2fxN/fxN mice did in fact display pro-
longed sinus bradycardia, a high-degree
AV conduction block, and AV dissocia-
tion prior to lethal asystole following sei-
zures, suggesting that SENP2 deficiency
affected the heart as well as the brain.
To determine whether the sudden death
phenotype in SENP2fxN/fxN mice was pri-
marily neurogenic or cardiogenic in origin,
the authors crossed SENP2fx/fx mice
(lacking the neomycin cassette) with
mice expressing either a tamoxifen-
inducible Thy1 Cre or a myosin heavy-
chain promoter Cre to generate
neuron-specific or cardiomyocyte-spe-
cific SENP2 deletion, respectively. Mice
with the cardiac-specific SENP2 deletion
had little to no phenotype. In contrast,
neuronal-specific SENP2 deletion re-
sulted in seizures and SUDEP. Combined
EEG and ECG recordings showed cortical
seizure activity, severe bradycardia, a
high-degree AV block, and lethal asystole
in neuron-specific SENP2 null mice.
Similar to the Scn1a+/ model of
Dravet Syndrome and SUDEP (Kalume
et al., 2013), neuronal-specific, but not
cardiac-specific, deletion of SENP2
recapitulated the global hypomorphic
phenotype, suggesting that the change
in neuronal excitability with hyper-
SUMOylation of K+ channels is respon-
sible for the SUDEP.
The cardiac abnormalities in the
Scn1a+/ model of Dravet are due to
postseizure increase in parasympathetic
tone (Kalume et al., 2013). Seizures in
SENP2fxN/fxN mice were reliably induced
with auditory stimulation and were used
by the authors to follow and charac-
terize whether seizures in these animals
were also due to parasympathetic tone.
Indeed, Qi and colleagues (Qi et al.,
2014) found that seizures were followed
by sinus pauses or AV conduction block,
which could be prevented by pretreat-
ment of the animals with atropine, but
not propranolol. Finally, to test whether
the SENP2 deficiency-induced reduction
of M-current is responsible for neu-
ronal hyperexcitability and SUDEP ineptember 3, 2014 ª2014 Elsevier Inc. 997
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the mice with M-channel openers to
determine whether this prevented the
development of pathophysiology. Indeed,
treatment of SENP2fxN/fxN mice with reti-
gabine effectively prevented the develop-
ment of audio-induced seizures and
postseizure AV block, suggesting that
SENP2 deficiency, leading to hyper-
SUMOylation of Kv7.2/7.3 and diminished
M-current, may be a primary cause of
epileptogenesis.
In summary, Qi and colleagues (Qi
et al., 2014) present a comprehensive
and compelling study demonstrating that
SENP2 deficiency, resulting in hyper-
SUMOylation of Kv7channels, causes the
development of spontaneous seizures,
cardiac abnormalities, and SUDEP in
mice. This impressive body of work iden-
tifies a new animal model of SUDEP, pre-
sents the first in vivo evidence for a
functional role of SUMOylation on ion
channel activity, and demonstrates that
hyper-SUMOylation of ion channel pro-
teins is an important molecular mecha-
nism and potential pathway for develop-
ment of novel epilepsy therapeutics.
These findings in mouse models suggest
that it may be informative to screen for ge-
netic variations in SENP genes in patients
with epilepsy. In addition to components
of the SUMO pathway, this important
work suggests that pharmacologicalmod-
ulation ofM-channel activitymaybeuseful
in preventing SUDEP in human patients.
SUMOylation is important not only for
K+ channel modulation but also for modu-
lation of other major participants in
neuronal excitability, at least in vitro.
Thus, the underlyingmechanism of hyper-998 Neuron 83, September 3, 2014 ª2014 Elexcitability and SUDEP in this mouse
model may involve additional players.
For example, SUMO has been shown to
modulate other ion channels, neurotrans-
mitter receptors, scaffolding proteins,
axon guidance molecules, and proteins
involved in synaptic function and neuro-
transmitter release (Luo et al., 2013; Wil-
kinson et al., 2010). In the Qi et al. study
(Qi et al., 2014), enhancement of M-cur-
rents via application of the M-channel
opener retigabine effectively suppressed
neuronal hyperexcitability and prevented
the development of seizures and ab-
normal cardiac activity. Though compel-
ling, this result is not definitive evidence
that hyper-SUMOylation of channels that
express M-current is the only underlying
defect in this mouse model. It is well
known that increasing M-channel activity
stabilizes the membrane potential and
effectively suppresses neuronal excit-
ability regardless of the primary insult.
Thus, in future studies it will be impor-
tant to explore other potential players
in the mechanism underlying SENP2
deficiency-induced hyperexcitability and
SUDEP. Another interesting future direc-
tion of this work is to understand the neu-
ronal subtypes involved in thismechanism.
Here, Qi et al. (2014) examined membrane
excitability and firing patterns in CA3
pyramidal cells. However, M-currents are
alsoexpressed inhippocampalGABAergic
interneurons (Grigorov et al., 2014). Are
these neurons also affected by SENP2
deficiency-induced hyper-SUMOylation?
If so, the plot of this story will thicken.
Nevertheless, this important and timely
work opens new avenues toward a cure
for epilepsy and SUDEP prevention.sevier Inc.REFERENCES
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